Home > PS Ratio > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
PS (Price/Sales) Ratio

The Current P/S Ratio of PROCTER & GAMBLE HEALTH is 6.34.

Share Price ₹4,720.7Apr 25,2024
Market Cap ₹7,836.4 Cr
Sales-TTM₹1,237.0 CrTTM-Standalone Results
Price/Sales6.34xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of PROCTER & GAMBLE HEALTH

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of PROCTER & GAMBLE HEALTH is calculated as :

Current Market Cap [ ₹7,836.4 Cr] as on Apr 25,2024

(/) Sales [ ₹1,237.0 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 6.34x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '6.34 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of PROCTER & GAMBLE HEALTH !

The chart below summarizes the trend in P/S Ratio of PROCTER & GAMBLE HEALTH over the last five years.

Historical PS (Price/Sales) ratio chart of PROCTER & GAMBLE HEALTH


PS Ratio Performance Analysis for PROCTER & GAMBLE HEALTH

- PROCTER & GAMBLE HEALTH 's latest p/e ratio is 6.34x.

- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Jun2023 to Dec2018 averaged 6.71x.

- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 6.24x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Jun2021 at 9.21x.

- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2020 of 4.98x.


How does PROCTER & GAMBLE HEALTH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
PROCTER & GAMBLE HEALTH 1,237.06.347,836.4
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.69364,831.0
CIPLA LTD25,350.24.48113,471.0
DR REDDYS LABORATORIES LTD27,212.53.81103,713.0
ZYDUS LIFESCIENCES LTD19,024.25.0395,687.8
DIVIS LABORATORIES LTD7,492.813.61101,960.0
MANKIND PHARMA LTD9,946.39.6696,093.1
TORRENT PHARMACEUTICALS LTD10,474.08.7091,124.7
LUPIN LTD19,480.13.7372,687.6
AUROBINDO PHARMA LTD27,894.72.3264,661.3
ABBOTT INDIA LTD5,753.49.4854,533.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PROCTER & GAMBLE HEALTH 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.32x
Max industry PS 13.61x
Median industry PS 6.34x
Average industry PS 6.80x



You may also like the below Video Courses